TCIM
INSM icon

TIAA CREF Investment Management’s Insmed INSM Stock Holding History

TIAA CREF Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$15.1M Buy
519,892
+312,165
+150% +$8.09M 0.01% 835
2018
Q4 		$2.73M Sell
207,727
-7,528
-3% -$120K ﹤0.01% 1771
2018
Q3 		$4.35M Sell
215,255
-11,227
-5% -$254K ﹤0.01% 1655
2018
Q2 		$5.36M Sell
226,482
-17,829
-7% -$459K ﹤0.01% 1553
2018
Q1 		$5.5M Sell
244,311
-313
-0.1% -$8.24K ﹤0.01% 1497
2017
Q4 		$7.63M Buy
244,624
+13,438
+6% +$397K 0.01% 1322
2017
Q3 		$7.21M Buy
231,186
+17,661
+8% +$336K ﹤0.01% 1385
2017
Q2 		$3.66M Buy
213,525
+1,857
+0.9% +$31.7K ﹤0.01% 1795
2017
Q1 		$3.71M Sell
211,668
-11,390
-5% -$176K ﹤0.01% 1779
2016
Q4 		$2.95M Sell
223,058
-6,108
-3% -$83.3K ﹤0.01% 1965
2016
Q3 		$3.33M Sell
229,166
-6,689
-3% -$83.7K ﹤0.01% 1869
2016
Q2 		$2.33M Sell
235,855
-6,143
-3% -$71.7K ﹤0.01% 2022
2016
Q1 		$3.07M Hold
241,998
– – ﹤0.01% 1836
2015
Q4 		$4.39M Sell
241,998
-5,065
-2% -$89.2K ﹤0.01% 1641
2015
Q3 		$4.59M Sell
247,063
-6,869
-3% -$171K ﹤0.01% 1591
2015
Q2 		$6.2M Buy
253,932
+46,464
+22% +$1.05M ﹤0.01% 1519
2015
Q1 		$4.32M Buy
207,468
+1,563
+0.8% +$27.5K ﹤0.01% 1744
2014
Q4 		$3.19M Sell
205,905
-10,102
-5% -$143K ﹤0.01% 1943
2014
Q3 		$2.82M Buy
216,007
+25,068
+13% +$378K ﹤0.01% 2000
2014
Q2 		$3.81M Buy
190,939
+20,372
+12% +$302K ﹤0.01% 1869
2014
Q1 		$3.25M Sell
170,567
-2,230
-1% -$42.4K ﹤0.01% 1925
2013
Q4 		$2.94M Buy
172,797
+6,300
+4% +$96.5K ﹤0.01% 2007
2013
Q3 		$2.6M Buy
166,497
+15,007
+10% +$191K ﹤0.01% 2044
2013
Q2 		$1.81M Buy
+151,490
New +$1.55M ﹤0.01% 2228

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

TIAA CREF Investment Management's INSM Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Insmed (INSM) stake by 150% in Q1 2019, buying an estimated $8.09M and bringing the position to 519,892 shares worth $15.1M. The position accounts for 0.01% of the portfolio, ranked #835.

TIAA CREF Investment Management first reported a position in INSM in Q2 2013 and has held it in 24 quarters since. 158 funds tracked by Wall St. Rank hold INSM as of Q1 2019.

  • TIAA CREF Investment Management held 519,892 shares of Insmed worth $15.1M as of Q1 2019.
  • TIAA CREF Investment Management bought 312,165 Insmed shares in Q1 2019, an estimated $8.09M.
  • Insmed made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #835 holding.
  • TIAA CREF Investment Management first reported a position in Insmed in Q2 2013 and has held it in 24 quarters since.
  • 158 funds tracked by Wall St. Rank held Insmed as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.